Remifentanil in Ventilated Preterm Infants

• Status: Terminated
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate efficacy of remifentanil in preterm infants during ventilator care with remifentanil and to analyze pharmacokinetics in preterm infants

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborators: Ajou University School of Medicine; DongGuk University
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• preterm infants (<37weeks of gestational age)

• requiring ventilator care

• informed consent

Exclusion Criteria:

• major anomaly

• 48hrs after birth

• requiring operation during drug infusion

• cord blood pH < 7.0

• intraventricular hemorrhage grade III or more

• investigators decision